Release Date: 12/07/18 08:25 Summary: Announcement on Unconditional Offer - on behalf of Offeror Price Sensitive: No Download Document 93.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%